


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-21.20%
-25.47%
-5.50%
-4.75%
+9.27%
WVE
Wave Life Sciences
$13.37
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
WVE Price Performance
$15 (-10.87%)
$8.04 (+66.29%)
$7.48 (+78.74%)
$11.03 (+21.21%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
WVE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
WVE Street Sentiment is bullish and have negative views on the near-term outlook
WVE has Medium risk level
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Dec 31, 2025
Upgrade
Buy
H.C. Wainwright
Dec 17, 2025
Reiterate
Outperform
Oppenheimer
Dec 13, 2025
Reiterate
Buy
B. Riley
Dec 12, 2025
Reiterate
Outperform
Wedbush
Dec 10, 2025
Reiterate
Buy
Canaccord Genuity
EBS
Emergent Biosolution
11.08
-2.89%
ARWR
Arrowhead Pharmaceuticals
65.61
-3.51%
What is WVE current stock price?
What are WVE stock strengths?
What is WVE Risk Level?
What is WVE market cap and volume?
What is WVE current Stock IQ?
Should I buy WVE stock right now?
Is WVE a Strong Buy right now?
What does a 'Strong Buy' rating mean for WVE?
What does a 'Strong Sell' rating mean for WVE?
What factors influence WVE's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-21.20%
-25.47%
-5.50%
-4.75%
+9.27%
WVE
Wave Life Sciences
Current Price
$13.37
Runners Also Watch
EBS
Emergent Biosolution
11.08
-2.89%
ARWR
Arrowhead Pharmaceuticals
65.61
-3.51%

WVE Price Performance
$15 (-10.87%)
$8.04 (+66.29%)
$7.48 (+78.74%)
$11.03 (+21.21%)
WVE Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
WVE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
WVE Street Sentiment is bullish and have negative views on the near-term outlook
WVE has Medium risk level
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Dec 31, 2025
Upgrade
Buy
H.C. Wainwright
Dec 17, 2025
Reiterate
Outperform
Oppenheimer
Dec 13, 2025
Reiterate
Buy
B. Riley
Dec 12, 2025
Reiterate
Outperform
Wedbush
Dec 10, 2025
Reiterate
Buy
Canaccord Genuity
Dec 10, 2025
Reiterate
Buy
Citigroup
Dec 10, 2025
Reiterate
Overweight
Wells Fargo
WVE Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
WVE Latest Analysis
Wave Life Sciences Reclaims Rare Disease Drug From GSK Targets Faster FDA Path. On Monday ) said it regained full rights to WVE-006 from ).The update follows agreement with GSK whose respiratory portfolio is focused on large-scale diseases that Wave is well placed to advance the in alpha-1 antitrypsin deficiency (AATD) a rare condition.AATD is an inherited genetic disorder caused by SERPINA1 gene mutations resulting in low levels of a protective protein (AAT) that leads to severe early-onset em
Mon Feb 2, 2026
Wave Life Sciences stock rises after regaining full rights to AATD therapy.
Mon Feb 2, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.